Literature DB >> 2462939

Respiratory burst in adherent human neutrophils: triggering by colony-stimulating factors CSF-GM and CSF-G.

C F Nathan1.   

Abstract

Human neutrophils adherent to proteins derived from serum or plasma, or to the basement membrane protein laminin, underwent a delayed but massive respiratory burst in response to recombinant human CSF-GM or CSF-G. No such response was elicited from neutrophils in suspension. On a molar basis, CSF-GM (EC50 approximately 126 pmol/L) and CSF-G (EC50 approximately 585 pmol/L) were about as potent as TNF alpha and TNF beta in their elicitation of H2O2 release and orders of magnitude more potent than previously studied formylated peptides or C5a. CSF-GM and CSF-G prime suspended neutrophils for a respiratory burst in response to soluble agonists, such as formylated peptides. Compared to the CSF-primed respiratory burst of nonadherent neutrophils, the CSF-triggered response of adherent neutrophils is markedly more delayed in onset (73 to 95 minutes), prolonged in duration (150 to 180 minutes), and greater in extent (approximately 60 to 100 nmol H2O2 released/10(6) neutrophils). Neither CSF-M, interleukin-3 (IL-3), nor bacterial lipopolysaccharide triggered the respiratory burst in adherent neutrophils, nor did CSF-GM or CSF-G trigger a respiratory burst in adherent monocytes. Release of CSF-GM and CSF-G in response to antigens, bacterial products, or cytokines may give mononuclear cells control over the respiratory burst of noncirculating neutrophils during inflammatory and immune responses.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2462939

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  61 in total

1.  A role for extracellular matrix binding receptors in regulating hematopoietic growth factor signaling.

Authors:  Richard B Gaynor
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-17       Impact factor: 11.205

Review 2.  Adherence-induced enhancement of the oxidative burst of human neutrophilic granulocytes: effects of the surface coat and of divalent cations.

Authors:  E Kownatzki; S Uhrich
Journal:  Agents Actions       Date:  1991-01

3.  The effect of starch-based biomaterials on leukocyte adhesion and activation in vitro.

Authors:  A P Marques; R L Reis; J A Hunt
Journal:  J Mater Sci Mater Med       Date:  2005-11       Impact factor: 3.896

4.  Effect of auranofin on cytokine induced secretion of granule proteins from adherent human neutrophils in vitro.

Authors:  J Richter
Journal:  Ann Rheum Dis       Date:  1991-06       Impact factor: 19.103

5.  Re-evaluation of the chemotactic activity of tumour necrosis factor for monocytes.

Authors:  J M Wang; S Walter; A Mantovani
Journal:  Immunology       Date:  1990-11       Impact factor: 7.397

6.  Granulocyte-macrophage colony-stimulating factor augments neutrophil killing of Torulopsis glabrata and stimulates neutrophil respiratory burst and degranulation.

Authors:  I C Kowanko; A Ferrante; D P Harvey; K L Carman
Journal:  Clin Exp Immunol       Date:  1991-02       Impact factor: 4.330

Review 7.  The multifaceted functions of neutrophils.

Authors:  Tanya N Mayadas; Xavier Cullere; Clifford A Lowell
Journal:  Annu Rev Pathol       Date:  2013-09-16       Impact factor: 23.472

8.  IL-6 and TNF alpha release in association with neutrophil activation after cardiopulmonary bypass surgery.

Authors:  R G Holzheimer; R G Molloy; H Görlach; S Wilkert; F Hehrlein
Journal:  Infection       Date:  1994 Jan-Feb       Impact factor: 3.553

9.  Regulation of intercellular adhesion molecule-1 (ICAM-1) in ischemic and reperfused canine myocardium.

Authors:  G L Kukielka; H K Hawkins; L Michael; A M Manning; K Youker; C Lane; M L Entman; C W Smith; D C Anderson
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

10.  The molecular basis for adhesion-mediated suppression of reactive oxygen species generation by human neutrophils.

Authors:  Tieming Zhao; Valerie Benard; Benjamin P Bohl; Gary M Bokoch
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.